CGEM: the cash flow

MyFinsight

For the quarter ending 2026-03-31, CGEM had -$13,251K decrease in cash & cash equivalents over the period.

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net loss	-49,661	-50,713	-50,610	-118,556
Equity-based compensation expense	7,616	7,312	9,467	19,261
Accretion on marketable securities	-777	-931	-1,358	-4,017
Depreciation and amortization	79	79	79	153
Prepaid expenses and other assets	662	-840	-798	-5,259
Accounts payable	1,667	-879	-739	779
Accrued expenses and other liabilities	-4,307	6,183	5,486	-3,643
Net cash used in operating activities	-46,045	-38,109	-36,877	-100,764
Maturities of marketable securities	52,549	42,000	80,000	294,572
Purchase of marketable securities	20,135	19,598	12,570	204,366
Purchase of property and equipment	-	11	38	-
Net cash provided by (used in) investing activities	32,414	22,391	67,392	90,206
Issuance of common stock and pre-funded warrants, net of issuance costs	-	0	0	0
Acquisition of noncontrolling interests	-	0	0	0
Issuance of common stock under equity-based compensation plans	380	715	0	373
Net cash provided by financing activities	380	715	0	373
Net increase in cash and cash equivalents	-13,251	-15,003	30,515	-10,185
Cash and cash equivalents at beginning of period	88,332	103,335	83,005	-
Cash and cash equivalents at end of period	75,081	88,332	103,335	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.